1st Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

Firm
Client
Income
—
Expenses
$137,033
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pandemic All-Hazards Preparedness Act (PAHPA) Reauthorization; Biodefense Advanced Research and Development Authority (BARDA) Funding in 2011 Continuing Resolution and President's FY-2012 Budget; Medical Countermeasures for Bacillus Anthracis including recombinant protective Antigen (rPA) vaccine and antitoxins.

LobbyistCovered position, as disclosed
MARK EDWARD COOKE Sr. Director Government Affairs

Contacted: Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.